• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by LifeStance Health Group Inc.

    3/17/25 4:05:38 PM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0002036749
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    LifeStance Health Group, Inc.
    SEC File Number
    001-40478
    Address of Issuer
    4800 N. SCOTTSDALE ROAD
    SUITE 2500
    SCOTTSDALE
    ARIZONA
    85251
    Phone
    602-767-2100
    Name of Person for Whose Account the Securities are To Be Sold
    Miller Lisa K
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    18845129993.3138455015203/17/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common11/10/2024Restricted Stock VestingIssuerCheckbox not checked1884511/10/2024Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    03/17/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Ryan Riviere, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lisa K. Miller

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    3/17/2022$19.00 → $10.00Buy → Neutral
    UBS
    More analyst ratings

    $LFST
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

      SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background

      3/12/24 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Financials

    Live finance-specific insights

    See more
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman

      Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz., Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer. Bourdon, who joined LifeStance as Chief Financial Officer in 2022, is succeeding Ken Burdick, who is retiring from his role as CEO and will assume the role of Executive Chairman. Bourdon has also been appointed to serve on the Board of Directors. In addition, Ryan McGroarty has been appointed to serve as the company's new Chief Financ

      2/27/25 6:02:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025

      SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 27, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 4372752, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentati

      2/6/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group upgraded by Goldman with a new price target

      Goldman upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $10.00

      12/16/24 6:31:31 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Pardo Ryan covered exercise/tax liability with 12,280 shares, decreasing direct ownership by 1% to 915,735 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:52:55 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Director Burdick Kenneth A covered exercise/tax liability with 35,817 shares, decreasing direct ownership by 1% to 3,368,901 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:35 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bourdon David covered exercise/tax liability with 10,884 shares, decreasing direct ownership by 1% to 888,239 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:06 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 4:34:15 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 9:59:56 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/8/24 4:33:25 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    SEC Filings

    See more
    • LifeStance Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/14/25 9:34:10 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeStance Health Group Inc.

      10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/7/25 4:42:46 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by LifeStance Health Group Inc.

      DEFA14A - LifeStance Health Group, Inc. (0001845257) (Filer)

      4/23/25 4:54:39 PM ET
      $LFST
      Medical/Nursing Services
      Health Care